PT496 – Juan Pablo Cappello – Maintenance Doses and Recurring Revenue: The Ethics of At-Home Ketamine Therapy

Psychedelics Today

In this episode, Joe interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves.

Cappello digs into his recent article which has been making waves across the psychedelic community: “Profit Over Patients? A Critical Look at At-Home Ketamine Therapy.” He created Nue Life with the goal of helping a million people address the root cause of their anxiety, and while the company was successful, he began to see a problematic trend: that using ketamine while providing services of a mental health company is very expensive and resource-consuming, and as companies saw a large percentage of clients requiring maintenance doses, the most profitable business model became essentially slinging ketamine to patients without providing any real integration or aftercare. Are these companies promising healing but really only guaranteeing recurring revenue?

He talks about:

• How this emerging model makes it harder for ethical practitioners to be able to provide their services
• The tools they built at Nue Life for long-term benefit, and why these should be the main focus – not repeated ketamine
• Matthew Perry’s death and how the media was quick to place the blame on ketamine
• The need for companies and communities to come to gather and create ethical industry standards for the at-home ketamine model
• How cannabis was almost decriminalized under the Carter administration

and more!

Click here to head to the show notes page.